Popular Articles

Obama's Health Reform Pitch Leaves Questions Unanswered For Many Viewers
The New York Times spoke to several families as they watched President Obama"s Wednesday night news conference. Thirty-six year old Craig Brown found that the event, meant to explain and gain support for health reform proposals, left him with many questions. He and his wife "remain frustrated by the lack of available detail about his plan"s contours and cost. They say they feel they are being asked to buy on spec from a government they do not trust. ... A similar unease was apparent in three other living rooms where families gathered to watch the news conference."
generic viagra online
Roche To Commence Phase III Trials With Innovative Treatment Designed To Lower Cardiovascular Risk In Diabetes Patients With Recent Heart Attack
Roche announced it will start Phase III clinical investigations for aleglitazar, its innovative PPAR co-agonist R1439 which is uniquely designed to reduce cardiovascular morbidity and mortality in high risk patients with type 2 diabetes. This decision is supported by data from the Phase II SYNCHRONY study published today in The Lancet(1) and announced at the American Diabetes Association meeting in New Orleans. The Phase III program is anticipated to start in the second half of 2009.
News of the day
CHMP Recommends Expanded Use Of ISENTRESS(R) (Raltegravir), From MSD, In Adult Patients With HIV-1 Infection
Merck Sharp & Dohme Limited (MSD) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending expanded marketing authorisation for "Isentress" (raltegravir) in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in all appropriate adult patients, including patients starting HIV therapy for the first time (treatment-naç¯ve), as well as treatment-experienced patients. The positive opinion will be reviewed by the European Commission, which grants marketing authorisation to the 27 countries that are members of the European Union (EU), as well as Iceland and Norway.
Medical Devices

The American Diabetes Association Celebrates The Recognition Of Gary Branham And John Griffin

The American Diabetes Association, the nation"s leading health organization in the fight to stop diabetes, is pleased to announce that the National Employment Lawyers Association has honored Gary Branham, who successfully fought discrimination based on diabetes, as one of three "Workplace Heroes & Heroines." The award honors those who have made a difference in the evolution of employee rights, and advancing equality and justice in the American workplace during the past twenty years. (For more information on this award, see http://www.nela.org.) Branham was recognized for prevailing in his landmark legal battle against the IRS, which had denied him a promotion from his position as a revenue officer to a special agent explicitly because of his diabetes. The agency had assumed that Branham, who takes insulin to control his diabetes, would be unable to safely perform the duties of the position; IRS"s decision failed to take into account clear medical evidence to the contrary, including the fact that Branham had maintained excellent control of his blood glucose for years. "I realized that my dream of becoming a special agent may never materialize, and I knew I had to take the IRS on, hoping that my struggle would help others with diabetes fight discrimination and live their dreams," said Branham. With the assistance of the Association, Branham filed a lawsuit against the federal government challenging this unjust discrimination, but the court threw out Branham"s case, finding that his diabetes was so well-managed that he did not have a disability, and therefore, was not protected against discrimination under federal law. Undaunted, Branham decided to continue the fight for fairness for workers with diabetes -- turning to John Griffin, a prominent Texas attorney and member of the Association"s Board of Directors (who himself has diabetes) to appeal the decision. Griffin successfully appealed to the U.S. Court of Appeals. Based on this decision, a trial was granted for Branham, and the jury issued a verdict finding that Branham is protected from discrimination and able to safely perform the special agent job. In addition, he was awarded compensation for six years of lost pay. Ironically, by the time his case had reached conclusion, Branham had exceeded the maximum age for special agent eligibility. "I am not disappointed," said Branham, "but truly encouraged now that this court and others have said that people with diabetes cannot be prevented from realizing their dreams based on stereotype or misinformation." "This is validation that people with diabetes can safely perform all types of jobs. Each person should be evaluated on a case-by-case basis. President Obama did just that when he nominated Judge Sonia Sotomayor, who, like Branham, has type 1 diabetes, to the Supreme Court of the United States," said Griffin. American Diabetes Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):